| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 281,2 k € | -14.2% | 327,7 k € | +25.0% | 262,3 k € | -2.6% | 269,2 k € | -9.9% | 298,7 k € | -1.9% | 304,4 k € | -51.3% | 624,6 k € | +38.9% | 449,8 k € | +3.4% | 434,8 k € | +4.5% | 416,2 k € | +23.6% | 336,8 k € | +8.9% | 309,4 k € | -9.9% | 343,5 k € | +11.2% | 308,8 k € | -2.6% | 317,1 k € | +363.5% | 68,4 k € | -57.1% | 159,3 k € | +161.5% | 60,9 k € | -31.9% | 89,5 k € | |
| EBITDA | 251,1 k € | -10.1% | 279,3 k € | +30.8% | 213,5 k € | -3.6% | 221,5 k € | -14.8% | 260,1 k € | -10.0% | 288,8 k € | -49.2% | 568,2 k € | +36.9% | 414,9 k € | +3.4% | 401,2 k € | +4.9% | 382,6 k € | +27.3% | 300,6 k € | +8.4% | 277,3 k € | -11.5% | 313,3 k € | +10.2% | 284,2 k € | -0.7% | 286,1 k € | +348.0% | 63,9 k € | -46.4% | 119,1 k € | +290.8% | 30,5 k € | -51.6% | 62,9 k € | |
| Operating profit | 169,4 k € | -21.2% | 214,9 k € | +57.2% | 136,7 k € | -2.4% | 140,0 k € | -19.7% | 174,5 k € | -11.5% | 197,1 k € | -53.0% | 419,0 k € | +36.2% | 307,5 k € | +3.5% | 297,2 k € | +5.3% | 282,2 k € | +36.2% | 207,2 k € | +10.9% | 187,0 k € | -17.5% | 226,5 k € | +11.9% | 202,4 k € | +74.4% | 116,1 k € | +268.4% | 31,5 k € | -55.1% | 70,1 k € | +489.8% | -18,0 k € | -784.8% | 2,6 k € | |
| Profit/loss | 116,2 k € | -34.1% | 176,3 k € | +103.8% | 86,5 k € | +7.5% | 80,5 k € | -32.6% | 119,4 k € | -29.7% | 169,9 k € | -40.4% | 285,1 k € | +51.4% | 188,3 k € | +33.0% | 141,5 k € | +1.3% | 139,7 k € | +10.5% | 126,4 k € | +6.3% | 118,9 k € | -0.9% | 120,0 k € | +21.5% | 98,8 k € | +92.9% | 51,2 k € | +261.2% | 14,2 k € | -65.9% | 41,6 k € | +296.6% | -21,2 k € | -463.1% | -3,8 k € | |
| Equity | 1,0 M € | -2.5% | 1,0 M € | +8.4% | 968,8 k € | +9.8% | 882,3 k € | -6.5% | 943,5 k € | -21.5% | 1,2 M € | +3.8% | 1,2 M € | +6.9% | 1,1 M € | +21.0% | 895,8 k € | +18.8% | 754,3 k € | +22.7% | 614,7 k € | +25.9% | 488,3 k € | +24.3% | 392,8 k € | +44.0% | 272,8 k € | +56.8% | 174,0 k € | +41.8% | 122,7 k € | +13.1% | 108,6 k € | +62.1% | 67,0 k € | -24.0% | 88,1 k € | |
| Total assets | 1,2 M € | -7.9% | 1,3 M € | +6.6% | 1,2 M € | -2.2% | 1,2 M € | -16.3% | 1,5 M € | -11.3% | 1,7 M € | +1.4% | 1,7 M € | +0.8% | 1,6 M € | +2.9% | 1,6 M € | +8.1% | 1,5 M € | +14.6% | 1,3 M € | +5.7% | 1,2 M € | +3.8% | 1,2 M € | -4.9% | 1,2 M € | -0.7% | 1,2 M € | +505.6% | 205,0 k € | -12.7% | 234,8 k € | +96.7% | 119,4 k € | -25.3% | 159,8 k € | |
| Cash | 394,4 k € | +273.1% | 105,7 k € | -54.7% | 233,5 k € | -49.8% | 464,7 k € | -26.7% | 634,0 k € | +5.7% | 599,9 k € | -1.5% | 608,7 k € | +67.8% | 362,8 k € | -7.7% | 393,1 k € | +20.3% | 326,8 k € | +82.3% | 179,2 k € | +45.7% | 123,0 k € | -9.2% | 135,5 k € | -17.3% | 163,8 k € | +7.4% | 152,5 k € | +42.4% | 107,1 k € | -1.3% | 108,5 k € | +112.3% | 51,1 k € | -12.7% | 58,5 k € | |
| Debts | 168,1 k € | -31.2% | 244,2 k € | +0.3% | 243,4 k € | -32.2% | 358,9 k € | -33.5% | 539,7 k € | +15.1% | 469,1 k € | -3.6% | 486,4 k € | -12.1% | 553,6 k € | -20.5% | 696,3 k € | -3.1% | 718,5 k € | +7.1% | 670,9 k € | -6.5% | 717,8 k € | -7.8% | 778,2 k € | -18.8% | 958,9 k € | -10.1% | 1,1 M € | +1236.9% | 79,7 k € | -35.6% | 123,8 k € | +147.9% | 49,9 k € | -27.8% | 69,2 k € | |
| Staff | — | — | — | — | — | — | — | — | — | 0,8 | 0,8 | 0,8 | 0,8 | 0,8 | 1 | — | 1 | 1 | 1 | |||||||||||||||||||
Private company with limited liability · Genk · incorporated on 02/03/1999
Private company with limited liability profitable and well capitalised. Cash position rising (+273.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. EERSELS is a Private company with limited liability incorporated in 1999. Its main activity is: General medical practice activities. Its registered office is in Genk.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette